Parameter | Primary outcome: intention Est (p-value) | Proximal intention | Comprehension Est (p-value) | User experience Est (p-value) | |||
---|---|---|---|---|---|---|---|
Attention Est (p-value) | Goals Est (p-value) | Action plan Est (p-value) | Review performance Est (p-value) | ||||
Intercept | 1.829 (< 0.001) | 1.812 (< 0.001) | 1.738 (< 0.001) | 1.608 (< 0.001) | 1.335 (< 0.001) | 2.011 (< 0.001) | 1.870 (< 0.001) |
Block | 0.09 (0.107) | −0.082 (0.120) | 0.026 (0.681) | −0.017 (0.799) | −0.093 (0.176) | −0.036 (0.390) | −0.042 (0.310) |
NCA (vs NDA) | |||||||
MINAP | −0.211 (0.317) | 0.521 (< 0.001) | −0.445 (0.069) | −0.482 (0.049) | 0.089 (0.607) | 0.140 (0.203) | 0.090 (0.407) |
NCABT | −0.893 (< 0.001) | 0.253 (0.115) | −0.638 (0.006) | −0.603 (0.011) | −0.565 (0.008) | 0.135 (0.292) | 0.118 (0.356) |
PICANet | 0.361 (0.270) | 0.755 (0.002) | 0.164 (0.657) | −0.263 (0.491) | 0.186 (0.548) | 0.312 (0.110) | 0.247 (0.206) |
TARN | −0.003 (0.989) | 0.304 (0.050) | 0.005 (0.984) | −0.275 (0.291) | 0.246 (0.208) | 0.022 (0.858) | 0.014 (0.908) |
Non-clinical (vs clinical) | −0.867 (< 0.001) | −0.489 (0.030) | −0.571 (0.015) | −0.290 (0.043) | |||
A:Effective comparator | −0.038 (0.498) | 0.015 (0.778) | 0.082 (0.190) | −0.018 (0.837) | −0.019 (0.784) | −0.091 (0.029) | −0.087 (0.036) |
B:Multimodal feedback | 0.018 (0.807) | 0.016 (0.766) | −0.061 (0.575) | −0.064 (0.313) | −0.052 (0.436) | 0.054 (0.198) | 0.048 (0.251) |
C:Specific actions | 0.082 (0.141) | −0.044 (0.400) | 0.065 (0.285) | 0.075 (0.240) | 0.118 (0.075) | 0.017 (0.679) | |
D:Optional detail | 0.017 (0.816) | 0.050 (0.415) | 0.051 (0.434) | 0.093 (0.174) | 0.022 (0.603) | 0.056 (0.176) | |
E:Patient voice | 0.078 (0.161) | 0.059 (0.343) | 0.064 (0.327) | 0.088 (0.201) | −0.057 (0.172) | ||
F:Cognitive load | 0.008 (0.890) | 0.126 (0.016) | 0.049 (0.656) | 0.044 (0.708) | 0.042 (0.533) | 0.103 (0.014) | |
A * B | −0.011 (0.844) | 0.083 (0.111) | 0.081 (0.190) | 0.073 (0.256) | 0.115 (0.089) | ||
A * C | −0.041 (0.500) | −0.080 (0.210) | |||||
A * D | 0.069 (0.266) | 0.095 (0.132) | 0.078 (0.068) | 0.085 (0.043) | |||
A * E | −0.014 (0.798) | −0.046 (0.458) | −0.044 (0.496) | −0.096 (0.153) | |||
A * F | −0.025 (0.696) | −0.032 (0.616) | |||||
B * C | −0.078 (0.138) | ||||||
B * D | −0.112 (0.047) | −0.114 (0.067) | −0.114 (0.008) | −0.115 (0.006) | |||
B * E | 0.035 (0.537) | 0.013 (0.832) | 0.026 (0.690) | ||||
B * F | 0.087 (0.089) | 0.057 (0.607) | −0.119 (0.085) | ||||
C * D | −0.107 (0.099) | −0.119 (0.078) | |||||
C * E | 0.066 (0.116) | ||||||
C * F | 0.093 (0.09) | 0.059 (0.338) | 0.050 (0.438) | ||||
D * E | 0.045 (0.469) | 0.085 (0.039) | |||||
D * F | −0.093 (0.089) | −0.123 (0.065) | −0.073 (0.079) | ||||
E * F | −0.008 (0.894) | ||||||
Additional interactions | |||||||
A * B * E = C * D * F | −0.101 (0.072) | −0.121 (0.053) | −0.137 (0.033) | ||||
A * C * F = B * D * E | 0.099 (0.109) | 0.159 (0.015) | |||||
A * D * E = B * C * F | 0.096 (0.136) | ||||||
A * E * F = B * C * D | −0.092 (0.132) | ||||||
Non-clinical * MINAP | 0.453 (0.117) | 0.721 (0.030) | 0.695 (0.040) | ||||
Non-clinical * NCABT | 1.312 (0.011) | 0.817 (0.146) | 0.829 (0.160) | ||||
Non-clinical * PICA | −0.783 (0.141) | −1.360 (0.021) | −0.708 (0.248) | ||||
Non-clinical * TARN | −0.017 (0.959) | −0.310 (0.406) | −0.135 (0.728) | ||||
A * Non-clinical | 0.185 (0.160) | ||||||
B * Non-clinical | −0.196 (0.083) | ||||||
D * Non-clinical | 0.195 (0.087) | ||||||
B * NCABT | 0.218 (0.247) | ||||||
B * MINAP | −0.101 (0.526) | ||||||
B * PICANet | 0.607 (0.035) | ||||||
B * TARN | −0.052 (0.775) | ||||||
F * NCABT | −0.135 (0.477) | 0.038 (0.846) | |||||
F * MINAP | −0.094 (0.561) | −0.022 (0.894) | |||||
F * PICANet | −0.080 (0.782) | −0.461 (0.132) | |||||
F * TARN | 0.357 (0.049) | 0.407 (0.033) | |||||
B * F * NCABT | −0.170 (0.372) | ||||||
B *F * MINAP | −0.400 (0.013) | ||||||
B *F * PICANet | 0.569 (0.046) | ||||||
B *F * TARN | −0.036 (0.840) | ||||||
Parameter estimates | |||||||
• +ve/−ve: positive or negative effect on outcome • Modification interactions + estimate = synergistic/−ve estimate = antagonistic |